Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Abiomed Inc (ABMD)

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,679,380
  • Shares Outstanding, K 45,047
  • Annual Sales, $ 840,880 K
  • Annual Income, $ 203,010 K
  • 60-Month Beta 1.17
  • Price/Sales 15.35
  • Price/Cash Flow 54.32
  • Price/Book 11.71
Trade ABMD with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.87
  • Number of Estimates 6
  • High Estimate 1.25
  • Low Estimate 0.52
  • Prior Year 1.03
  • Growth Rate Est. (year over year) -15.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
255.40 +9.91%
on 10/02/20
291.33 -3.64%
on 10/19/20
+15.65 (+5.90%)
since 09/18/20
3-Month
255.40 +9.91%
on 10/02/20
319.19 -12.05%
on 08/05/20
-10.07 (-3.46%)
since 07/20/20
52-Week
119.01 +135.88%
on 03/23/20
319.19 -12.05%
on 08/05/20
+105.42 (+60.14%)
since 10/18/19

Most Recent Stories

More News
Studies Presented at TCT Connect Associate Higher Survival With Early Identification of Right Heart Failure and Early Use of Impella RP

Data presented at TCT Connect, the 32nd annual scientific symposium of the Cardiovascular Research Foundation, finds early identification of right heart failure and early use of Impella RP is associated...

ABMD : 280.64 (-0.29%)
Data Presented at TCT Connect Finds Pre-PCI Use of Impella for AMI Cardiogenic Shock is Associated with Higher Survival, Particularly in Women

Two studies of AMI cardiogenic shock (AMICS) patients found higher survival when Impella was placed pre-PCI, compared to when Impella was placed after PCI. The findings were presented at TCT Connect, the...

ABMD : 280.64 (-0.29%)
Abiomed to Host a Virtual Meeting to Discuss New Clinical Data Presented at TCT Connect

Abiomed, Inc. (NASDAQ: ABMD) announced it will host a virtual investor meeting on Tuesday, October 20, 2020 at 8:00 a.m. EDT to review new clinical data presented at TCT Connect, the 32nd annual scientific...

ABMD : 280.64 (-0.29%)
Largest Study of Hemodynamically Supported High-Risk PCI Patients Finds More Complete Revascularization with Impella Leads to Improved Outcomes

Abiomed (NASDAQ: ABMD) announces new PROTECT III study data that demonstrates reduced rates of MACCE (composite of death, stroke, myocardial infarction and repeat procedures) when Impella is used to achieve...

ABMD : 280.64 (-0.29%)
IART vs. ABMD: Which Stock Is the Better Value Option?

IART vs. ABMD: Which Stock Is the Better Value Option?

IART : 47.87 (+0.13%)
ABMD : 280.64 (-0.29%)
Restore EF Study Demonstrates Impella-Supported High-Risk PCI Improves Left Ventricular Ejection Fraction

The Restore EF Study demonstrates the use of contemporary best practices, including attempting a more complete revascularization with Impella-supported high-risk PCI, is associated with significant improvement...

ABMD : 280.64 (-0.29%)
Abiomed Second Quarter Fiscal 2021 Earnings and Conference Call Notification

Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, October 29, 2020, the Company will release financial results for the second quarter of fiscal 2021. The Company will host a conference call to discuss...

ABMD : 280.64 (-0.29%)
TCT Connect to Highlight How Impella Enables Improved Outcomes for High-Risk PCI, Cardiogenic Shock and Right Heart Failure Patients

The benefits of a more complete revascularization with Impella heart pumps in high-risk percutaneous coronary intervention (PCI) patients and the value of Impella protocol-based treatment for survival...

ABMD : 280.64 (-0.29%)
Axogen, Inc. Appoints Paul G. Thomas to Board of Directors

Healthcare veteran brings 30+ years of medtech experience to Axogen, Inc. Board of Directors

AXGN : 13.39 (-0.37%)
ABMD : 280.64 (-0.29%)
SRGA : 1.98 (-1.00%)
Abiomed Inc Shares Down 6.4% Since SmarTrend's Sell Call (ABMD)

SmarTrend identified a Downtrend for Abiomed Inc (NASDAQ:ABMD) on September 4th, 2020 at $283.16. In approximately 3 weeks, Abiomed Inc has returned 6.43% as of today's recent price of $264.94.

ABMD : 280.64 (-0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing...

See More

Key Turning Points

2nd Resistance Point 295.39
1st Resistance Point 288.43
Last Price 280.64
1st Support Level 277.41
2nd Support Level 273.35

See More

52-Week High 319.19
Last Price 280.64
Fibonacci 61.8% 242.72
Fibonacci 50% 219.10
Fibonacci 38.2% 195.48
52-Week Low 119.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar